You won’t find our model elsewhere: eCOA strategy, a powerful DCT platform, and a full-service site team—under one virtual roof.
Our DCT solutions are powered by ObvioGo®, a highly-configurable and AI-enabled platform that accommodates a broad spectrum of trial protocols—from heavily site-based to fully virtual. This flexibility gives you the freedom to design a clinical trial that will deliver stronger therapeutic evidence.
Technology is a great enabler. But, it isn’t sufficient to fill studies and keep participants engaged. And, participants aren’t the only stakeholders who need support. ObvioHealth’s suite of services complements our DCT platform to ensure trial sponsors, sites, and patients can deliver successful studies.
Effective clinical trial design should be solution-neutral—prioritizing the approach that delivers the strongest evidence. Have a look below to see how our solutions work along the DCT spectrum, from site-centric to fully virtual or somewhere in between.
ObvioHealth has deep clinical trial experience. We launched one of the first-ever DCT platforms with a mobile app in 2017. Today, we’re a global industry leader delivering DCTs that generate stronger evidence.